Cordyceps Sunshine Biotech Holdings Co., Ltd. (RAJAF)
OTCMKTS · Delayed Price · Currency is USD
5.20
+2.19 (72.76%)
At close: Nov 7, 2025
RAJAF Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 0 | 0.04 | 0.02 | 0.01 | 0.1 |
Cash & Short-Term Investments | 0 | 0.04 | 0.02 | 0.01 | 0.1 |
Cash Growth | -91.42% | 61.38% | 248.58% | -93.35% | 33806.12% |
Accounts Receivable | - | 0 | - | - | 0.36 |
Other Receivables | 0.01 | - | - | 0.01 | 0.02 |
Receivables | 0.01 | 0 | - | 0.01 | 0.37 |
Inventory | 0.67 | - | - | - | 0.48 |
Prepaid Expenses | 0.21 | 0.2 | 0.11 | - | - |
Other Current Assets | 0.1 | 0.36 | 0.2 | 0.49 | 0.18 |
Total Current Assets | 1 | 0.6 | 0.33 | 0.5 | 1.13 |
Property, Plant & Equipment | 3.65 | 4.01 | 3.01 | 0.25 | 1.99 |
Other Long-Term Assets | 0.01 | 0.01 | 0.01 | 1.35 | - |
Total Assets | 4.66 | 4.62 | 3.35 | 2.1 | 3.26 |
Accounts Payable | 0.37 | 0.28 | 0.19 | - | 1.23 |
Accrued Expenses | 0.09 | 0.03 | 0.03 | - | 0.06 |
Short-Term Debt | - | - | - | - | 1.56 |
Current Portion of Long-Term Debt | 0.47 | 0.45 | - | - | - |
Current Portion of Leases | 0.01 | 0.09 | 0.09 | 0.06 | 0.07 |
Current Income Taxes Payable | - | 0.02 | 0.02 | - | 0 |
Other Current Liabilities | 4.26 | 4.12 | 2.64 | 2.46 | 0.01 |
Total Current Liabilities | 5.19 | 4.99 | 2.97 | 2.52 | 2.92 |
Long-Term Debt | - | - | 0.43 | 0.41 | 0.41 |
Long-Term Leases | - | 0.01 | 0.11 | 0.12 | 0.2 |
Total Liabilities | 5.19 | 5 | 3.5 | 3.06 | 3.54 |
Common Stock | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
Additional Paid-In Capital | 0.22 | 0.22 | 0.22 | 0.22 | - |
Retained Earnings | -0.85 | -0.7 | -0.47 | -1.22 | -0.5 |
Comprehensive Income & Other | 0.09 | 0.09 | 0.09 | 0.04 | 0.22 |
Shareholders' Equity | -0.53 | -0.38 | -0.15 | -0.95 | -0.28 |
Total Liabilities & Equity | 4.66 | 4.62 | 3.35 | 2.1 | 3.26 |
Total Debt | 0.48 | 0.55 | 0.63 | 0.59 | 2.24 |
Net Cash (Debt) | -0.48 | -0.51 | -0.6 | -0.59 | -2.14 |
Net Cash Per Share | -0.00 | -0.00 | -0.01 | -0.01 | -0.02 |
Filing Date Shares Outstanding | 111.12 | 111.12 | 111.12 | 111.12 | 111.12 |
Total Common Shares Outstanding | 111.12 | 111.12 | 111.12 | 111.12 | 100 |
Working Capital | -4.19 | -4.39 | -2.64 | -2.02 | -1.79 |
Book Value Per Share | -0.00 | -0.00 | -0.00 | -0.01 | -0.00 |
Tangible Book Value | -0.53 | -0.38 | -0.15 | -0.95 | -0.28 |
Tangible Book Value Per Share | -0.00 | -0.00 | -0.00 | -0.01 | -0.00 |
Buildings | - | - | - | - | 0.69 |
Machinery | - | 0.11 | 0.16 | 0.1 | 1.21 |